Showing results (41-50 of 50) with videos related to
Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Cellular Signalling|July 6, 2006
RGS2 promotes formation of neurites by stimulating microtubule polymerizationKyun Heo, Sang Hoon Ha, Young Chan Chae, et al.Frontiers in Immunology|October 12, 2023
A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variantsJi Woong Kim, Hyun Jung Kim, Kyun Heo, et al.Journal of Medical Virology|March 6, 2024
Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptidesJi Woong Kim, Ji Hyun Lee, Hyun Jung Kim, et al.Oral Oncology|January 31, 2012
Hypoxia-induced up-regulation of apelin is associated with a poor prognosis in oral squamous cell carcinoma patientsKyun Heo, Yun Hee Kim, Ho Jin Sung, et al.Cancer Letters|November 6, 2013
Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse modelYun-Hee Kim, Ju Young Moon, Eun-Ok Kim, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|March 31, 2023
Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatmentSun Il Choi, Yu-Sun Lee, Yul Min Lee, et al.Molecular and Cellular Biology|May 15, 2004
NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activationYong-Seok Oh, Nam Won Jo, Jung Woong Choi, et al.Molecular Oncology|January 10, 2018
Inhibition of VEGF-dependent angiogenesis and tumor angiogenesis by an optimized antibody targeting CLEC14aTaek-Keun Kim, Chang Sik Park, Jihye Jang, et al.Antiviral Research|March 4, 2023
Novel bispecific human antibody platform specifically targeting a fully open spike conformation potently neutralizes multiple SARS-CoV-2 variantsJi Woong Kim, Kyun Heo, Hyun Jung Kim, et al.Cancer Letters|November 21, 2017
Inhibition of BMP signaling overcomes acquired resistance to cetuximab in oral squamous cell carcinomasJinlong Yin, Ji-Eun Jung, Sun Il Choi, et al.Pageof 5